Unlock stock picks and a broker-level newsfeed that powers Wall Street.
0.4641
+0.0033
+(0.72%)
At close: April 1 at 4:00:02 PM EDT
0.4650
+0.00
+(0.19%)
After hours: April 1 at 7:58:58 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 5 | 5 |
| Avg. Estimate | -0.1 | -0.1 | -0.43 | -0.36 |
| Low Estimate | -0.12 | -0.1 | -0.65 | -0.53 |
| High Estimate | -0.09 | -0.09 | -0.35 | -0.2 |
| Year Ago EPS | -0.2 | -0.17 | -0.63 | -0.43 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 6 | 6 |
| Avg. Estimate | 1.26M | 1.33M | 8.6M | 12.92M |
| Low Estimate | -- | -- | -- | 3.1M |
| High Estimate | 1.9M | 2.2M | 22.1M | 36.4M |
| Year Ago Sales | 1.13M | 1.65M | 31.08M | 8.6M |
| Sales Growth (year/est) | 11.73% | -19.25% | -72.33% | 50.28% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.2 | -0.19 | -0.17 | -0.12 |
| EPS Actual | -0.2 | -0.17 | -0.18 | -0.09 |
| Difference | 0 | 0.02 | -0.01 | 0.03 |
| Surprise % | 0.00% | 8.79% | -7.52% | 27.86% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.1 | -0.1 | -0.43 | -0.36 |
| 7 Days Ago | -0.1 | -0.1 | -0.37 | -0.36 |
| 30 Days Ago | -0.12 | -0.13 | -0.5 | -0.44 |
| 60 Days Ago | -0.12 | -0.13 | -0.5 | -0.44 |
| 90 Days Ago | -0.12 | -0.13 | -0.5 | -0.44 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | 2 |
| Up Last 30 Days | 1 | 1 | 1 | 2 |
| Down Last 7 Days | -- | -- | 1 | 1 |
| Down Last 30 Days | -- | -- | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| LXRX | 48.34% | 43.14% | 32.14% | 16.26% |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/28/2025 |
| Maintains | Piper Sandler: Overweight to Overweight | 3/7/2025 |
| Reiterates | Needham: Hold to Hold | 3/7/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/7/2025 |
| Downgrade | Leerink Partners: Outperform to Market Perform | 3/4/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/3/2025 |
Related Tickers
PRTG Portage Biotech Inc.
8.26
-10.70%
OCEA Ocean Biomedical, Inc.
0.0549
+1.67%
OSRH OSR Holdings, Inc.
1.7200
-8.51%
DBVT DBV Technologies S.A.
6.46
-5.28%
DRMA Dermata Therapeutics, Inc.
0.9997
-7.44%
THTX Theratechnologies Inc.
1.4000
0.00%
SNSE Sensei Biotherapeutics, Inc.
0.3450
-12.44%
PSTV Plus Therapeutics, Inc.
1.0200
+7.36%
LPTX Leap Therapeutics, Inc.
0.2913
-4.52%
RNAZ TransCode Therapeutics, Inc.
0.5409
+9.27%